SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-006615
Filing Date
2022-05-02
Accepted
2022-05-02 15:30:37
Documents
4
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220614xdef14a.htm DEF 14A 893383
2 GRAPHIC tmb-20220614xdef14a005.jpg GRAPHIC 100664
3 GRAPHIC tmb-20220614xdef14a004.jpg GRAPHIC 115974
4 GRAPHIC tmb-20220614xdef14a003.jpg GRAPHIC 78625
  Complete submission text file 0001558370-22-006615.txt   1301677
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32295 | Film No.: 22881573
SIC: 2836 Biological Products, (No Diagnostic Substances)